Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Biological therapy boosts the immune system to effectively fight melanoma.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Cetuximab can cause unusual hair growth and hair loss.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Intralesional cidofovir may be a viable alternative treatment for SCC.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.